First-Year Results from Medtronic and UnitedHealthcare Value-Based Relationship Demonstrate Significantly Reduced Preventable Hospital Admissions

27 percent fewer preventable hospital admissions for Medtronic insulin pump users compared to patients on multiple daily injections of insulin

DUBLIN (July 10, 2018) – Medtronic and UnitedHealthcare announced first-year results from an innovative value-based relationship focused on delivering patient-centered solutions that improve health outcomes related to managing diabetes.

Results from an analysis of over 6,000 UnitedHealthcare plan participants with diabetes on Medtronic insulin pumps demonstrated 27 percent fewer preventable hospital admissions vs. plan participants who are on multiple daily injections of insulin (MDI).

“These positive results provide further evidence of the benefits to patients of both automated insulin delivery and value-based health care models” said Hooman Hakami, Executive Vice President and President of the Diabetes Group at Medtronic. “Through this unique relationship, Medtronic and UnitedHealthcare have prioritized innovation that improves health outcomes and lowers health care costs. At Medtronic, our commitment is to drive innovation with the clear objective of delivering demonstrable value to patients and to the health care system. Our hope is that the entire health care community follows UnitedHealthcare’s lead to not only champion innovations in diabetes with clear and measurable ties to better outcomes and lower cost, but to also reward those results as they are achieved.”

This data reflects first year results of a multiyear initiative between UnitedHealthcare and Medtronic. Both quality of care and cost will continue to be closely evaluated over the duration of the relationship, providing additional opportunities for more people enrolled in UnitedHealthcare plans to better manage their diabetes and for quality care to be delivered in a more cost-effective manner.

“These results show that patients with diabetes can benefit from using insulin pumps and comprehensive support services, thereby increasing the quality of the care they receive and reducing hospital admissions as well as costs,” said Peter Pronovost, M.D., Chief Medical Officer. “The first-year results are encouraging, and we will monitor patients using Medtronic pump therapies to ensure we continue to see improved quality of care, fewer hospitalizations and lower costs.”

Care providers nationwide are showing strong interest in a shift to value-based care. UnitedHealthcare’s total payments to physicians and hospitals that are tied to value-based arrangements have grown in the last three years to $65 billion. By the end of 2020, UnitedHealthcare expects that figure to reach $75 billion. For more information about UnitedHealthcare’s changing relationships with care providers and how value-based programs are helping to improve quality and people’s health, visit and download the Value-based Care Report.

About the Diabetes Group at Medtronic (
Medtronic is working together with the global community to change the way people manage diabetes. The company aims to transform diabetes care by expanding access, integrating care, and improving outcomes, so people living with diabetes can enjoy greater freedom and better health.

About Medtronic

Medtronic plc (, headquartered in Dublin, Ireland, is among the world’s largest medical technology, services, and solutions companies – alleviating pain, restoring health, and extending life for millions of people around the world. Medtronic employs more than 85,000 people worldwide, serving physicians, hospitals, and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

About UnitedHealthcare

UnitedHealthcare is dedicated to helping people live healthier lives and making the health system work better for everyone by simplifying the health care experience, meeting consumer health and wellness needs, and sustaining trusted relationships with care providers. In the United States, UnitedHealthcare offers the full spectrum of health benefit programs for individuals, employers, and Medicare and Medicaid beneficiaries, and contracts directly with more than 1.2 million physicians and care professionals, and 6,500 hospitals and other care facilities nationwide. The company also provides health benefits and delivers care to people through owned and operated health care facilities in South America. UnitedHealthcare is one of the businesses of UnitedHealth Group (NYSE: UNH), a diversified health care company. For more information, visit UnitedHealthcare at or follow @UHC on Twitter.